The outbreak of Covid-19 pandemic in Tajikistan has amplified its multi-faceted vulnerabilities and precariousness to shocks. After officially announcing the first 15 cases of Covid-19 on April 30, 2020, the number of confirmed cases has continued to rise and by July 9, 2020, the total number of cases had already reached 6,410 including 54 deaths.1 Tajikistan’s already weak healthcare system makes the task of containing Covid-19 even more challenging. There is limited testing capacity with only a few laboratories certified to conduct polymerase chain reaction (PCR) tests in the country. There is also a limited supply of testing kits and reagents which is affecting the number of tests being carried out. The Covid-19 medical response is already stretching the entire health care system in Tajikistan. As a result, routine clinical services, hospitalization, and immunization programmes are getting affected.